We then injected 107 outgrown cells/mouse, representing the upper range of potential clinical doses of cells/kg, in HIGM1 mice conditioned either with two different doses of CPA, anti‐lymphocyte serum (ALS), or an anti‐CD4 antibody (Fig 6A). Here, CD4 is linked to amyotrophic lateral sclerosis.